|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/89 | |
| A61K 31/4412 | |||
| A61P 29/00 |
| (11) | Number of the document | 2748146 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12741219.5 |
| Date of filing the European patent application | 2012-07-20 | |
| (97) | Date of publication of the European application | 2014-07-02 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/047559 |
| Date | 2012-07-20 |
| (87) | Number | WO 2013/016174 |
| Date | 2013-01-31 |
| (30) | Number | Date | Country code |
| 201161510832 P | 2011-07-22 | US |
| (72) |
PENNELL, Andrew, M.K., US
UNGASHE, Solomon, US
|
| (73) |
ChemoCentryx, Inc.,
850 Maude Avenue, Mountain View California 94043,
US
|
| (54) | A CRYSTALLINE FORM OF THE SODIUM SALT OF 4-TERT-BUTYL-N-[4-CHLORO-2-(1-OXY-PYRIDINE-4-CARBONYL)-PHENYL]-BENZENE SULFONAMIDE |
| A CRYSTALLINE FORM OF THE SODIUM SALT OF 4-TERT-BUTYL-N-[4-CHLORO-2-(1-OXY-PYRIDINE-4-CARBONYL)-PHENYL]-BENZENE SULFONAMIDE |